Navigation Links
Tengion Presents New Data Supporting its Organ Regeneration Platform™ at 8th Annual Meeting of the International Society for Stem Cell Research
Date:6/17/2010

siness and operations, the forward-looking statements are neither promises nor guarantees and the company's business is subject to significant risk and uncertainties, and there can be no assurance that its actual results will not differ materially from its expectations. These risks and uncertainties include, among others: (i) we may have difficulty enrolling patients in our clinical trials, including our Phase I clinical trial for our Neo-Urinary Conduit; (ii) patients enrolled in our clinical trials may experience adverse events related to our product candidates, which could delay our clinical trials or cause us to terminate the development of a product candidate; and (iii) we may be unable to progress our product candidates that are undergoing preclinical testing into clinical trials.  For further information with respect to factors that could cause the company's actual results to differ materially from expectations, reference is made to the reports the company filed with the Securities and Exchange Commission under the Securities Exchange Act of 1934, as amended. The forward-looking statements made in this release are made only as of the date hereof and the company disclaims any intention or responsibility for updating predictions or expectations contained in this release.


'/>"/>
SOURCE Tengion Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Preclinical Efficacy Data Demonstrate Ability of Tengions Neo-Bladder Augment to Restore Bladder Function
2. Tengion to Present at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
3. Tengion Appoints Jeff Randall to Board of Directors
4. Tengion Announces European Orphan Drug Designation for Neo-Bladder Augment
5. Tengion Appoints Mark Stejbach Vice President of Marketing & Commercial Planning
6. Tengion Scientists Publish Positive Preclinical Findings With Neo-Organ Demonstrating Long-term Durability and Growth With Skeletal Maturation
7. Tengion Featured as Model of Innovation and Success at 35th Anniversary Celebration of the National Venture Capital Association
8. Tengion Announces Second Closing of Series C Financing
9. Tengion to Present at the Piper Jaffray 20th Annual Healthcare Conference
10. Tengion Presents New Data Supporting Key Urologic and Kidney Programs at 16th Annual Meeting of the International Society for Cellular Therapy
11. Lexicon Presents Class of Compounds Modulating TPH1, the Target for its LX1031 Investigational Drug for Irritable Bowel Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... --  Sequenom, Inc. (NASDAQ: SQNM ), ... solutions, and Mayo Medical Laboratories (MML), the ... the United States , have announced a license ... "We have great appreciation for Mayo Clinic,s commitment ... the opportunity to partner with the organization,s leading clinical ...
(Date:7/29/2014)... 2014) Tough, ultralight foam of atom-thick sheets can ... chemical process invented at Rice University. , In ... nanoscale building, with floors and walls that reinforce each ... materials: floors and walls of graphene oxide that self-assemble ... , The researchers say the foam could find use ...
(Date:7/29/2014)... NEW YORK , July 29, 2014  Pomerantz ... Impax Laboratories, Inc. ("Impax" or the "Company") (NASDAQ: IPXL).  ... Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. ... certain of its officers and/or directors have violated Sections ... 1934.  On July 29, 2014, Impax ...
(Date:7/29/2014)... Pa. , July 29, 2014  Discovery ... dedicated to advancing a new standard of respiratory ... results on August 5, 2014 before the open ... The Company will host a live teleconference and ... During the conference call, Discovery Labs, management will ...
Breaking Biology Technology:Sequenom Enters Into License Agreement With Mayo Medical Laboratories 2Sequenom Enters Into License Agreement With Mayo Medical Laboratories 3Sequenom Enters Into License Agreement With Mayo Medical Laboratories 4Tough foam from tiny sheets 2SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Impax Laboratories, Inc. - IPXL 2Discovery Labs to Report 2014 Second Quarter Financial Results and Hold Conference Call on Tuesday, August 5, 2014 at 9:00 a.m. Eastern Time 2
... Christenson will assume duties as director of the state ... Secretary Cory Nettles announced the hire last ... initiative. , ,Part of the key to our ... in collaborative efforts. We hope to connect the tech ...
... For Ron Reynolds, an early peek at what would turn ... Way came through a hole in the ceiling. , ,As ... late 1970s, Reynolds sawed a hole in the ceiling of ... a specially built spectrometer through the roof of the building, ...
... of molten steel as the representative symbol of a ... the cubicle farm. Instead of coke and iron ore, ... data and information into knowledge and ideas: An invisible ... output is knowledge. Every physical product has a knowledge ...
Cached Biology Technology:Nettles Names Christenson as Director of Bureau of Entrepreneurship 2Journey Leads Astronomer to New Galactic Structure 2Journey Leads Astronomer to New Galactic Structure 3Transforming Information to Knowledge 2
(Date:7/29/2014)... Northern Territories in Canada and have sent smoke drifting ... on. NASA,s Aqua satellite collected this natural-color image ... July 26, 2014. Actively burning areas, detected by MODIS,s ... smoke are drifting northward in this image. Smoke ... Fire has caused power outages in the area and ...
(Date:7/29/2014)... Kent has shown for the first time how the ... could have a major impact on cancer therapy development. ... the mechanism whereby the physical properties of the internal ... are ,fine-tuned, to undertake different functions. , While some ... a framework for the cell, others are more dynamic, ...
(Date:7/29/2014)... ground breaking new book that brings together two of ... raise the profile of insect fossils through stunning photographs ... Penney and James E Jepson, details the incredible preservation ... setting the scene for what these remarkable fossils can ... even the future of our planet. Like the mosquito ...
Breaking Biology News(10 mins):Unique images bring fossil insects back to life 2
... engineered yeast strain can simultaneously consume two types of ... sugars are glucose, a six-carbon sugar that is relatively ... has been much more difficult to utilize in ethanol ... adding to earlier advances, reduces or eliminates several major ...
... 24, 2010) - Three weeks of oral resveratrol or ... microRNA activity close to their pre-event levels in excised ... were attributed to exerting the majority of the gene-switching ... microRNA optimally regulated by Longevinex and two optimally by ...
... New findings from the Monell Center reveal that weight ... formula the infant is consuming. The findings have implications related ... and other diseases later in life. "Events early in ... most significant influences is early growth rate," said study lead ...
Cached Biology News:Team overcomes major obstacles to cellulosic biofuel production 2Team overcomes major obstacles to cellulosic biofuel production 3Team overcomes major obstacles to cellulosic biofuel production 4Longevinex exerts greater influence over genes than resveratrol 2Longevinex exerts greater influence over genes than resveratrol 3Not all infant formulas are alike: Differential effects on weight gain 2
Mouse monoclonal [4i144] to HLA Class II DQ1 7 ( Abpromise for all tested applications). Antigen: Full length protein (Human): HLA Class 2 Antigen DQ1,7....
ASCIZ...
Goat polyclonal to CHMP5 ( Abpromise for all tested applications). Antigen: Synthetic peptide: C-NKDGVLVDEFGLPQ, corresponding to C terminal amino acids 202-215 of Human CHMP5 Entrez GeneID: ...
...
Biology Products: